Systemic complications of acromegaly and the impact of the current treatment landscape: an update

MR Gadelha, L Kasuki, DST Lim… - Endocrine reviews, 2019 - academic.oup.com
Acromegaly is a chronic systemic disease with many complications and is associated with
increased mortality when not adequately treated. Substantial advances in acromegaly …

Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement

HG Pope Jr, RI Wood, A Rogol, F Nyberg… - Endocrine …, 2014 - academic.oup.com
Despite the high prevalence of performance-enhancing drug (PED) use, media attention has
focused almost entirely on PED use by elite athletes to illicitly gain a competitive advantage …

Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002)

SR Cairns, JH Scholefield, RJ Steele, MG Dunlop… - Gut, 2010 - gut.bmj.com
The British Society of Gastroenterology (BSG) and the Association of Coloproctology for
Great Britain and Ireland (ACPGBI) commissioned this update of the 2002 guidance. The …

Systemic complications of acromegaly: epidemiology, pathogenesis, and management

A Colao, D Ferone, P Marzullo, G Lombardi - Endocrine reviews, 2004 - academic.oup.com
This review focuses on the systemic complications of acromegaly. Mortality in this disease is
increased mostly because of cardiovascular and respiratory diseases, although currently …

[HTML][HTML] Insulin, insulin-like growth factors and colon cancer: a review of the evidence

E Giovannucci - The Journal of nutrition, 2001 - Elsevier
Insulin and insulin-like growth factor (IGF) axes are major determinants of proliferation and
apoptosis and thus may influence carcinogenesis. In various animal models, modulation of …

Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3

J Ma, MN Pollak, E Giovannucci… - Journal of the …, 1999 - academic.oup.com
BACKGROUND: Insulin-like growth factor-I (IGF-I) is a potent mitogen for normal and
neoplastic cells, whereas IGF-binding protein-3 (IGFBP-3) inhibits cell growth in many …

Mortality and cancer incidence in acromegaly: a retrospective cohort study

SM Orme, RJQ McNally, RA Cartwright… - The Journal of …, 1998 - academic.oup.com
abstract Patients with acromegaly have a reduced life expectancy, with the accepted causes
for premature death being vascular and respiratory disease. Increased mortality from …

Criteria for cure of acromegaly: a consensus statement

A Giustina, A Barkan, FF Casanueva… - The Journal of …, 2000 - academic.oup.com
In February 1999, a workshop was held in Cortina, Italy to develop a consensus defining the
criteria for cure of acromegaly. The workshop was sponsored by the University of Brescia …

Modifiable risk factors for colon cancer

E Giovannucci - Gastroenterology Clinics, 2002 - gastro.theclinics.com
In the United States, colorectal cancer is the third leading cause of cancer deaths in each
sex and second for both sexes combined [1]. At current rates, approximately 6% of …

Insulin-like growth factors and cancer

G Fürstenberger, HJ Senn - The lancet oncology, 2002 - thelancet.com
Interest in insulin-like growth factors (IGFs) and their effect on carcinogenesis has increased
recently because high serum concentrations of IGF1 are associated with an increased risk of …